Danielle Shafer

996 total citations
30 papers, 398 citations indexed

About

Danielle Shafer is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Danielle Shafer has authored 30 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Danielle Shafer's work include Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Danielle Shafer is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Danielle Shafer collaborates with scholars based in United States. Danielle Shafer's co-authors include Arushi Khurana, Steven Grant, Tahseen Al‐Saleem, Hossein Borghaei, Mitchell R. Smith, Hong Wu, Dipankar Bandyopadhyay, Kathy S. Albain, Mary Beth Tombes and Taha Al‐Juhaishi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American Academy of Dermatology.

In The Last Decade

Danielle Shafer

30 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Shafer United States	12	169	151	118	85	49	30	398
H. Eugene Liu Taiwan	10	260 1.5×	124 0.8×	70 0.6×	48 0.6×	27 0.6×	16	436
Shinsuke Mizutani Japan	11	188 1.1×	115 0.8×	121 1.0×	127 1.5×	55 1.1×	50	400
Yaozhong Zhao China	10	184 1.1×	149 1.0×	92 0.8×	110 1.3×	65 1.3×	47	410
Miki Kiyota Japan	10	137 0.8×	93 0.6×	104 0.9×	107 1.3×	49 1.0×	23	319
Matko Kalac United States	9	220 1.3×	148 1.0×	47 0.4×	161 1.9×	52 1.1×	37	423
Mecide Gharibo United States	12	175 1.0×	197 1.3×	146 1.2×	71 0.8×	57 1.2×	34	400
Anna Colpo Italy	11	133 0.8×	71 0.5×	104 0.9×	46 0.5×	77 1.6×	24	376
Neil Palmisiano United States	13	156 0.9×	228 1.5×	162 1.4×	128 1.5×	54 1.1×	64	491
Harald Biersack Germany	13	219 1.3×	242 1.6×	196 1.7×	116 1.4×	72 1.5×	33	560

Countries citing papers authored by Danielle Shafer

Since Specialization

Citations

This map shows the geographic impact of Danielle Shafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Shafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Shafer more than expected).

Fields of papers citing papers by Danielle Shafer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Shafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Shafer. The network helps show where Danielle Shafer may publish in the future.

Co-authorship network of co-authors of Danielle Shafer

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Shafer. A scholar is included among the top collaborators of Danielle Shafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Shafer. Danielle Shafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shafer, Danielle, Dale Schaar, Dipankar Bandyopadhyay, et al.. (2025). A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome. Cancer Chemotherapy and Pharmacology. 95(1). 24–24. 5 indexed citations

Shafer, Danielle, Michelle A. Rudek, Maciej Kmieciak, et al.. (2023). Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies. Cancer Chemotherapy and Pharmacology. 91(3). 281–290. 14 indexed citations

Duong, Vu H., Kebede H. Begna, Kendra Sweet, et al.. (2020). Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study. Annals of Hematology. 99(9). 2119–2124. 6 indexed citations

Al‐Juhaishi, Taha, Arushi Khurana, & Danielle Shafer. (2019). Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks. Best Practice & Research Clinical Haematology. 32(1). 47–53. 15 indexed citations

Khurana, Arushi & Danielle Shafer. (2019). <p>MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)</p>. OncoTargets and Therapy. Volume 12. 2903–2910. 79 indexed citations

Khurana, Arushi, Taha Al‐Juhaishi, Victor Yazbeck, & Danielle Shafer. (2019). Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes. Blood. 134(Supplement_1). 4013–4013. 2 indexed citations

Shafer, Danielle, Zhijian Chen, Timothy Harris, et al.. (2017). Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma multiforme.. Journal of Clinical Oncology. 35(15_suppl). 2060–2060. 2 indexed citations

Shafer, Danielle & Steven Grant. (2016). Update on rational targeted therapy in AML. Blood Reviews. 30(4). 275–283. 59 indexed citations

Poklepovic, Andrew, Sarah Gordon, Danielle Shafer, et al.. (2016). Phase I study of pemetrexed with sorafenib in advanced solid tumors. Oncotarget. 7(27). 42625–42638. 8 indexed citations

10.

Park, Haeseong & Danielle Shafer. (2014). Disseminated histoplasmosis in peripheral blood smear. Blood. 123(10). 1445–1445. 3 indexed citations

11.

Shafer, Danielle, Mitchell R. Smith, Hossein Borghaei, et al.. (2013). Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. Leukemia Research. 37(10). 1213–1215. 32 indexed citations

12.

Ellimoottil, Chandy, et al.. (2012). A Case of Primary Renal Lymphoma. Urology. 80(4). 763–765. 14 indexed citations

13.

Shafer, Danielle & Kathy S. Albain. (2009). Lung Cancer Outcomes in Women. Seminars in Oncology. 36(6). 532–541. 12 indexed citations

14.

Michaelis, Laura C., Danielle Shafer, Kevin Barton, et al.. (2009). Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.. Blood. 114(22). 1034–1034. 4 indexed citations

15.

Shafer, Danielle, Hong Wu, Tahseen Al‐Saleem, et al.. (2008). Cutaneous Precursor B-Cell Lymphoblastic Lymphoma in 2 Adult Patients. Archives of Dermatology. 144(9). 1155–62. 26 indexed citations

16.

Jambusaria, Anokhi, Danielle Shafer, Hong Wu, Tahseen Al‐Saleem, & Clifford Perlis. (2008). Cutaneous plasmablastic lymphoma. Journal of the American Academy of Dermatology. 58(4). 676–678. 23 indexed citations

17.

Langer, Corey J., Karen Ruth, Hossein Borghaei, et al.. (2007). PD3-2-8: Phase II Trial of Cetuximab (C225) in Combination with Monthly Carboplatin (Cb) and Weekly Paclitaxel (Pac) in Patients with Advanced NSCLC: Promising Early Results. Journal of Thoracic Oncology. 2(8). S465–S466. 1 indexed citations

18.

Jillella, Anand P., Danielle Shafer, Thomas R. Klumpp, Robert Emmons, & Kenneth F. Mangan. (2007). Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; Conversion to full donor chimerism. American Journal of Hematology. 82(6). 419–426. 12 indexed citations

19.

Borghaei, Hossein, Mitchell R. Smith, Michael Millenson, et al.. (2006). Phase I Trial of Combination Therapy with 90Y Ibritumomab Tiuxetan and Gemcitabine in Patients with Non-Hodgkin’s Lymphoma.. Blood. 108(11). 4710–4710. 1 indexed citations

20.

Grbic, John T., et al.. (2003). Analysis of inflammatory mediators in TMJ synovial fluid lavage samples of symptomatic patients and asymptomatic controls. Journal of Oral and Maxillofacial Surgery. 61(8). 66–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact